Feature Centurion BioPharma targeting strategic alliance for LADR drug conjugates by year’s end By Len Zehrs Centurion BioPharma, a newly-created private subsidiary of CytRx (NASDAQ:CYTR), is currently in discussions with a number of pharma companies for a strategic alliance to continue development of its patient... July 10, 2018